PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.12%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.95%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-79.40%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-83.45%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-66.33%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-66.18%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-65.67%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.50%
Share reduction while NXPI is at 0.41%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.49%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
22.98%
Dividend growth of 22.98% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-9.73%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-5.99%
Negative FCF growth while NXPI is at 18.28%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
103.30%
Positive 10Y revenue/share CAGR while NXPI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
3.27%
Positive 5Y CAGR while NXPI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
10.62%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
113.57%
10Y OCF/share CAGR under 50% of NXPI's 517.63%. Michael Burry would worry about a persistent underperformance in cash creation.
-6.01%
Negative 5Y OCF/share CAGR while NXPI is at 517.63%. Joel Greenblatt would question the firm’s operational model or cost structure.
20.95%
3Y OCF/share CAGR under 50% of NXPI's 517.63%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
165.64%
Net income/share CAGR above 1.5x NXPI's 73.28% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-56.90%
Negative 5Y net income/share CAGR while NXPI is 73.28%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-55.02%
Negative 3Y CAGR while NXPI is 73.28%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
49.55%
Positive growth while NXPI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
35.46%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
25.81%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
856.00%
Dividend/share CAGR of 856.00% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
109.92%
Dividend/share CAGR of 109.92% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
76.00%
3Y dividend/share CAGR of 76.00% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-24.21%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.92%
Inventory is declining while NXPI stands at 6.56%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.41%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.07%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-8.21%
Our R&D shrinks while NXPI invests at 11.76%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-5.08%
We cut SG&A while NXPI invests at 22.03%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.